Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Hyperparathyroidism (SHPT)”

45 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 45 results

Post-approval studies (Phase 4)Study completedNCT00418600
What this trial is testing

A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis

Who this might be right for
Secondary Hyperparathyroidism
Genzyme, a Sanofi Company 36
Large-scale testing (Phase 3)Looking for participantsNCT03969329
What this trial is testing

Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis

Who this might be right for
Secondary Hyperparathyroidism
Amgen 24
Testing effectiveness (Phase 2)Study completedNCT06236295
What this trial is testing

Investigating the Safety and Efficacy of SHR6508 Injection in the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients : A Multicenter, Long-term Clinical Trial

Who this might be right for
Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
Shanghai Hengrui Pharmaceutical Co., Ltd. 303
Large-scale testing (Phase 3)Study completedNCT01932970
What this trial is testing

Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 158
Testing effectiveness (Phase 2)WithdrawnNCT01453634
What this trial is testing

Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018)

Who this might be right for
Stage 5 Chronic Kidney Disease (CKD)Secondary Hyperparathyroidism (SHPT)Hemodialysis (HD)
OPKO Health, Inc.
Large-scale testing (Phase 3)Study completedNCT00117052
What this trial is testing

SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism

Who this might be right for
Secondary HyperparathyroidismEnd Stage Renal Disease
Amgen 673
Large-scale testing (Phase 3)Looking for participantsNCT03633708
What this trial is testing

A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
Amgen 56
Post-approval studies (Phase 4)Study completedNCT03123406
What this trial is testing

Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT

Who this might be right for
Hyperparathyroidism; Secondary, Renal
Kyowa Kirin China Pharmaceutical Co., Ltd. 750
Large-scale testing (Phase 3)Study completedNCT01785875
What this trial is testing

Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 891
Post-approval studies (Phase 4)Study completedNCT00110890
What this trial is testing

A Research Study for Patients With End-Stage Renal Disease (ESRD)

Who this might be right for
End Stage Renal Disease
Amgen 552
Testing effectiveness (Phase 2)Study completedNCT06690242
What this trial is testing

MT1013 Injection for the Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease

Who this might be right for
Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
Shaanxi Micot Pharmaceutical Technology Co., Ltd. 115
Post-approval studies (Phase 4)Study completedNCT00803712
What this trial is testing

20070360 Incident Dialysis

Who this might be right for
Chronic Kidney DiseaseSecondary Hyperparathyroidism
Amgen 313
Post-approval studies (Phase 4)Study completedNCT01181531
What this trial is testing

Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 312
Testing effectiveness (Phase 2)Looking for participantsNCT06976177
What this trial is testing

Study of MT1013 Injection for the Treatment of Secondary Hyperparathyroidism (SHPT) Patients With Chronic Kidney Disease Undergoing Maintenance Dialysis

Who this might be right for
Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
Shaanxi Micot Pharmaceutical Technology Co., Ltd. 310
Not applicableStudy completedNCT01073462
What this trial is testing

Study to Evaluate the Effect of Intravenous (IV) Paricalcitol (Zemplar) on Cardiac Morbidity in Patients With Chronic Kidney Disease (CKD) Stage 5 Over 2 Years

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease Stage VCardiac Morbidity
AbbVie (prior sponsor, Abbott) 67
Post-approval studies (Phase 4)Study completedNCT00823303
What this trial is testing

Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
Washington University School of Medicine 110
Large-scale testing (Phase 3)Study completedNCT02102204
What this trial is testing

Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 902
Early research (Phase 1)Study completedNCT00888069
What this trial is testing

Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects

Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismChronic Renal Insufficiency+1 more
OPKO IP Holdings II, Inc. 28
Large-scale testing (Phase 3)Study completedNCT03299244
What this trial is testing

Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT)

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
Amgen 637
Not applicableLooking for participantsNCT05997810
What this trial is testing

Parathyroid Tumor Clonal Status

Who this might be right for
Parathyroid TumorPrimary HyperparathyroidismSecondary Hyperparathyroidism (SHPT)+1 more
Washington University School of Medicine 839
Next Page